Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

FDA clears AI-powered cardiac imaging platform
The Tempus Pixel platform was designed to assist clinicians with the evaluation of cardiac MR images.
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Open-source AI model delivers accurate echocardiography assessments
The algorithm, trained on more than 150,000 TTE studies, can calculate 18 different measurements regularly used in echocardiography
ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.
Cardiologist Carlos Collet takes new leadership role with CRF
Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.

Artificial intelligence (AI) analysis from a remote ECG monitor showing the AI generated report on the Philips Cardiologs system, during a demonstration of the technology at Heart Rhythm 2023. Photo by Dave Fornell

AI correctly IDs ventricular arrhythmias in 88% of patients with sustained VT

New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.

The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Imaging results more helpful than genetics when predicting heart disease, new head-to-head study confirms

The new analysis, published in JAMA, suggests that CT results can help identify medium- and high-risk patients who may need to be considered for statin therapy or other preventive treatments.

Daniel Cantillon, MD, said the first leadless, dual-chamber pacing system performed very well in the Aveir dual-chamber i2i trial. #HRS #HRS23

Early success of dual-chamber leadless pacemaker suggests big changes could be on the horizon

Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care.

Get Ready: CT-guided PCI Is Coming to a Cath Lab Near You

Sponsored by GE HealthCare

Change is on the horizon for cath labs all over the world as more and more interventional cardiologists are starting to use coronary CT angiography to plan and guide PCI procedures. Patients, physicians, catheterization labs and healthcare systems all stand to gain from this growing trend.

A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

Electrophysiology experts issue recommendations for remote monitoring of CIEDs

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

The EBR Systems WiSE leadless cardiac resynchronization therapy (CRT) system. #HRS23

A leadless pacemaker the size of a grain of rice delivers cardiac resynchronization therapy

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

Left bundle branch pacing emerges as an alternative to biventricular pacing in two late-breaking trials

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

Cardiac Imaging

FDA clears AI-powered cardiac imaging platform

Key trends in nuclear cardiology take center stage at ASNC 2025

Open-source AI model delivers accurate echocardiography assessments

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging

Cardiologist Carlos Collet takes new leadership role with CRF